In this section we combine our interests in the intercellular dialogues which control the emigratory, secretory and proliferative properties of monocytes. T cells and endothelial cells under in vitro conditions and in the complex milieu of tissue reactions. Employing delayed type skin reactions in man we wish to understand the structural and functional phenotypes of emigratory cells with monoclonal reagents and in situ hybridization probes. Employing recombinant lymphokines and monokines we wish to examine their selective roles in the cellularity of the delayed response and their influence on the process of emigration, the proliferative epidermal reactions and the turnover of Langerhans cells. Employing cultured endothelial cells (EC) we wish to define the selective binding properties of blood monocytes, the nature of the binding sites in the junctional complexes and the biochemical determinant which regulate the production of the arachidonate metabolites arising from the cyclooxygenase and lipoxygenase pathways. In particular, the unique priming effects of bacterial LPS for markedly enhanced secretion of vaso active metabolites. This and other subprojects of this proposal will be focussed on a new clinical and laboratory program to understand the basic immunological defects in patients with AIDS. Employing the facilities of the Hospital of The Rockefeller University we will examine the cellular tropisms of HTLV-III, defects in the endocytic and secretory repertoire of mononuclear phagocytes, factors controlling DTH reactions and the nature of Kaposi's sarcoma cells.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Haslett, P; Hempstead, M; Seidman, C et al. (1997) The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Res Hum Retroviruses 13:1047-54
Moreira, A L; Corral, L G; Ye, W et al. (1997) Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. AIDS Res Hum Retroviruses 13:857-63
Klausner, J D; Makonkawkeyoon, S; Akarasewi, P et al. (1996) The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol 11:247-57
Bender, A; Sapp, M; Schuler, G et al. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-35
Berman, M E; Xie, Y; Muller, W A (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 156:1515-24
Frankel, S S; Wenig, B M; Burke, A P et al. (1996) Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115-7
Granelli-Piperno, A; Moser, B; Pope, M et al. (1996) Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 184:2433-8
Tramontana, J M; Utaipat, U; Molloy, A et al. (1995) Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1:384-97
Pope, M; Betjes, M G; Hirmand, H et al. (1995) Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J Invest Dermatol 104:11-7
Muller, W A (1995) The use of anti-PECAM reagents in the control of inflammation. Agents Actions Suppl 46:147-57

Showing the most recent 10 out of 88 publications